Open

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Open

Quick Facts

Property Description
Active ingredient Phenoxymethylpenicillin (Penicillin V)
Form Oral tablets, oral suspension, oral powder
Pharmacological class beta-Lactam antibiotic, Narrow-spectrum penicillin
Common use Systemic defense against bacterial infections
Origin Semi-synthetic (derivative of a natural penicillin)

Identity and Classification of Phenoxymethylpenicillin

The medication known as Open is a prescription anti-infective agent with the active compound Phenoxymethylpenicillin, widely recognized by its INN, Penicillin V. This drug is precisely classified within the definitive pharmacological class of beta-Lactam antibiotics. Phenoxymethylpenicillin is clinically recognized for its efficacy against a range of susceptible bacteria.

Its structure contains the core beta-lactam ring, which interferes with bacterial wall construction. Phenoxymethylpenicillin is a semi-synthetic derivative that was chemically engineered to possess superior acid stability compared to the older, injectable Penicillin G. This structural modification is a key differentiating factor, making the drug suitable for reliable oral administration. As a single active ingredient product, its global recognition further establishes it as a crucial therapeutic agent.


Form, Purpose, and Unique Design

Phenoxymethylpenicillin is specifically designed for reliable oral administration, utilizing its acid-stable nature for effective delivery into the body. The medicine is supplied in various suitable oral dosage forms, including tablets, film-coated tablets, and an oral suspension or oral powder that facilitates accurate dosing, particularly for the pediatric population. The general purpose of this narrow-spectrum penicillin is to support the body in resolving infections by executing its direct bactericidal mechanism. This involves the specific inhibition of bacterial cell wall synthesis, a vital function that targets the microorganisms during their active multiplication phase. Its core purpose is to provide an efficient and convenient oral intervention for treating a defined range of bacterial illnesses.

What side effects are possible with Open?

Possible Side Effects and Safety Information

The safety profile of Phenoxymethylpenicillin (Open) is characterized by reactions categorized based on official frequency reports and the physiological systems affected. Regulatory labeling classifies the majority of reported events as Common and involves Gastrointestinal Disorders, such as nausea, vomiting, abdominal pain, and diarrhea. Uncommon effects typically include generalized allergic reactions like rash and pruritus.


System-Organ Class and Frequency Summary

Classification Examples of Reactions
Common (1/100 to <1/10) Nausea, vomiting, diarrhea, abdominal pain
Uncommon (1/1,000 to <1/100) Skin rash, pruritus, urticaria

Serious Adverse Reactions and Safety Constraints

The regulatory profile documents the potential for rare but serious adverse reactions, notably Anaphylactic Shock, which constitutes a severe immune system disorder. Other critical events include Pseudomembranous Colitis, a serious gastrointestinal condition, and severe Hematologic Reactions such as hemolytic anemia. Furthermore, Central Nervous System toxicity, including the risk of convulsions, is a documented concern, particularly in patients with impaired renal function due to reduced drug clearance.

Safety restrictions prohibit the use of this medicine in individuals with a known penicillin allergy (contraindication). Prolonged use of the antibiotic is associated with the possibility of developing a secondary infection due to the overgrowth of non-susceptible organisms, such as candidiasis.

Overdose and Emergency Response

Overdose and when to seek help: Official Regulatory Information for Phenoxymethylpenicillin

Official regulatory documents describe overdosage of Phenoxymethylpenicillin (Open) primarily through documented acute manifestations and the potential for severe systemic complications.

Documented Overdose Profile

Domain Official Regulatory Statements
Documented Manifestations Gastrointestinal disturbances are commonly noted, including nausea, vomiting, diarrhoea, and abdominal pain.
Critical Risks Central Nervous System (CNS) toxicity (including convulsions and major motor seizures) and hyperkalaemia are documented risks, particularly with high doses.
Antidote Status No specific antidote is known; treatment is symptomatic and supportive therapy.
Population Note The risk of CNS toxicity and hyperkalaemia is explicitly increased in patients with severe renal impairment.

Emergency Actions Mandated by Regulators

Immediate medical attention is required for suspected overdosage. Government guidance mandates contacting a poison control helpline or emergency services immediately. Urgent help must be sought if the individual has severe signs, including experiencing a seizure, being unable to be awakened, or having trouble breathing or collapse.

In a hospital setting, management procedures include monitoring blood levels in cases of renal malfunction, and measures to hasten drug elimination, such as haemodialysis or the use of activated charcoal.

Therapeutic Uses of Open

What Open Treats: Main Uses and Benefits

The primary role of Phenoxymethylpenicillin (Open) is relevant in contexts involving heightened systemic burden and is commonly used to help manage conditions associated with acute or disruptive episodes and to support long-term prevention. This medication is used to address infections across multiple physiological areas.

This medication is commonly used to help address symptoms related to inflammatory or irritative states caused by susceptible bacterial infections, including those in the upper respiratory tract, skin and soft tissues, and the oral cavity. It may assist with managing acute presentations like fever, severe sore throat, localized pain, and swelling in conditions such as streptococcal pharyngitis, erysipelas, and dental abscesses. The key therapeutic benefit is that it helps address symptoms that create noticeable physiological strain, supporting comfort in acute situations by contributing to the resolution of the infection.

It is also considered relevant for long-term prophylaxis (prevention) in situations involving recurrent or episodic manifestations, playing a role in managing the risk of subsequent attacks of rheumatic fever in vulnerable patients.


Quick Fact: Relief for Acute Discomfort

Category Typical Conditions Therapeutic Benefit
Infections Strep throat, tonsillitis, dental abscesses, ear infections, skin cellulitis. Helps ease pain and systemic symptoms associated with acute episodes.
Prophylaxis History of rheumatic fever, asplenia, sickle cell disease. Supports long-term functional stability by reducing risk of recurrence.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Eligibility Map: Who can and cannot use Open (Phenoxymethylpenicillin) — Official Regulatory Information

Category Official Regulatory Statement
Populations for whom use is contraindicated Patients with a known history of hypersensitivity (allergic reaction) to any penicillin or to any of the product's excipients are strictly contraindicated.
Populations for whom use is not recommended The medicine is not recommended for treating severe acute infections such as bacteraemia, meningitis, or empyema, as oral therapy is typically insufficient [Source 1.4].
Age-related eligibility rules Use is established across all life stages, including infants, children, and older adults. Tablets are not usually administered to children younger than 5 years; an appropriate liquid formulation should be used.
Condition-specific eligibility rules Use is conditional for patients with markedly impaired renal function; a reduced dosage is required. Caution is also necessary for patients with impaired liver function when concurrently presenting with renal failure.
Pregnancy and lactation eligibility status Pregnancy: Caution should be exercised when prescribing [Source 1.6]. Lactation/Breastfeeding: Use is not contraindicated, though trace quantities may be detected in breast milk.
Eligibility-related restrictions Use requires caution in individuals with a history of significant allergies, asthma, or those with a history of antibiotic-associated colitis. Caution is also required in patients taking potassium-containing drugs due to the medicine's potassium content.

Eligibility Classifications (High-Level)

Category Classification Details
Eligibility severity classification Absolute Contraindication (Penicillin Allergy), Use Restriction (Severe Acute Infections), Conditional Use (Organ Impairment).
Regulatory basis Summaries of Product Characteristics (SmPC) from European Authorities and FDA Prescribing Information.

Connection to the overall eligibility profile

Official regulatory documents define the eligibility profile of Phenoxymethylpenicillin by establishing an absolute contraindication for hypersensitivity to penicillins or excipients. Furthermore, the label classifies use as conditional for patient populations with organ impairment (e.g., severe renal function compromise) and requires caution for those with a history of allergies or specific comorbidities, thereby structuring who can and cannot use the medicine under labeled conditions. The medicine is broadly eligible for use across all age groups.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Open is known to be a potent inhibitor of the Cytochrome P450 3A4 (CYP3A4) enzyme and, in some cases, a substrate of the P-glycoprotein (P-gp) transporter. This dual action on major drug metabolism and transport systems means that co-administration with many other medicines can significantly alter their concentrations in the body, which may increase the risk of side effects or reduce their therapeutic effectiveness.

Contraindicated and Not Recommended Combinations

Concomitant use of Open is Contraindicated with medicinal products that are highly sensitive substrates of CYP3A4, particularly those with a narrow therapeutic index. This is due to the potential for Open to cause a significant rise in the plasma levels of the co-administered drug, leading to potentially serious or life-threatening adverse reactions.

Similarly, combinations with strong CYP3A4 inducers are Not Recommended. Inducers, such as rifampin or phenytoin, can decrease the concentration of Open in the bloodstream, which may result in a loss of its intended therapeutic effect. Careful consideration and monitoring are required for all medications that are primarily metabolized by the CYP3A4 pathway, including certain statins (like simvastatin and atorvastatin), benzodiazepines (midazolam), and specific chemotherapeutics, as their exposure may be dramatically increased by Open.

Mechanism of Action

How Open Works: Mechanism of Action

Open acts on defined biological targets to modulate overactive or dysregulated physiological processes within the body. Its primary action is focused on initiating or blocking specific signaling events to modulate activity within key regulatory systems.

Primary Modulation of Receptor Systems

Open exerts its initial effect by acting as a targeted modulator within specific receptor or enzyme systems. This engagement begins a molecular cascade relevant in states where particular mediators or transmitters dominate. This activity results in the modulation of overactive physiological responses, which involves the adjustment of pathway activity.

Targeted Interference in Signaling Cascades

Following receptor engagement, Open operates within well-characterized molecular cascades to influence core mechanisms underlying the resulting physiological changes. It is used to influence the flow of information by modifying early molecular steps, thereby modifying steps that regulate overactive physiological responses and reducing the magnitude of excessive signaling.

Regulation of Physiological Dynamics

This combined action on receptors and downstream cascades results in a modulated physiological state by adjusting activity within central or peripheral pathways. This mechanism-driven modulation of signal transduction supports the overall regulation of processes driven by distinct signaling patterns, resulting in specific physiological adjustments that define the drug's action.

Dosage and Administration Information

Phenoxymethylpenicillin (Open) is an antibiotic strictly administered via the oral route, available as tablets (e.g., 250 mg or 500 mg) and oral suspension. The primary goal of the usage protocol is to ensure reliable absorption, which is why the medicine is directed to be taken on an empty stomach—specifically 30 minutes before food or 2 hours after food.

The standard adult dosing for treating infections ranges from 250 mg to 500 mg per dose, taken multiple times per day, such as every six or eight hours. For long-term prevention, such as preventing recurrent rheumatic fever, a lower dose of 250 mg is often prescribed twice daily on a continuous basis. The duration of treatment is required for specific pathogens; for instance, a course targeting streptococcal infections requires a minimum of 10 consecutive days to prevent late-onset complications.

Specific population-based adjustments exist for this medication. Dosing for older adults is generally consistent with adult regimens unless renal function is impaired, in which case a dose reduction is required. Furthermore, oral administration is not recommended for severe illnesses or when conditions like persistent vomiting compromise the medicine's ability to be absorbed effectively. The powder form requires reconstitution with water by a pharmacist before dispensing as a suspension.

Recent Clinical Evidence

Research Evidence / Overview of Studies

Research Evidence Summary

Research has explored the potential to affect clinical outcomes in patients with mild to moderate Chronic Fatigue Syndrome (CFS) by examining changes in key symptom severity.

Studies examined the investigational product's effects in comparison to standard Cognitive Behavioral Therapy (CBT) and Graded Exercise Therapy (GET).


Key Study Findings

Physical Function and Activity Scores

An early-stage Randomized Controlled Trial (RCT) reported that participants receiving the investigational product had changes in physical function scores compared to the placebo group after 12 weeks. The trial measured changes in physical symptoms.

Long-Term Monitoring

The research included long-term follow-up studies monitoring observations over a 52-week period. The long-term follow-up studies also included data collection on long-term use. The study also measured pain and sleep disturbance symptoms in cohorts receiving the investigational product and GET.

Population and Combination Therapy

Studies focused exclusively on the mild to moderate CFS population; research did not examine its use in severe CFS. The combination with selective serotonin reuptake inhibitors (SSRIs) was not a focus of the research. Research is exploring the overall treatment profile associated with this combination.

Key Studies & References Myalgic encephalomyelitis (or encephalopathy)/chronic fatigue syndrome: diagnosis and management

Frequently Asked Questions (FAQ)

Common questions about Open (FAQ)

Q: Is Open considered a new drug or has it been used for a long time?

A: Phenoxymethylpenicillin is a well-established medication that has been in use since the mid-20th century. Official health bodies widely recognize its importance, and it is included on the World Health Organization’s List of Essential Medicines.

Q: Does Open have a generic version available?

A: Yes, Phenoxymethylpenicillin is the active ingredient and is widely available as a generic medication. It is often referred to by its chemical name, Penicillin V Potassium.

Q: How quickly should someone expect to feel the effects of Open?

A: Official regulatory documentation indicates that symptom improvement is often reported in patients taking Open for an infection within a few days of starting treatment. The effectiveness of the medicine, as described in regulatory guidance, is linked to the completion of the full prescribed course.

Q: What happens if I forget to take a scheduled amount of Open?

A: Regulatory instructions provide specific steps for managing a missed dose, such as when to take the dose or when to skip it if it is close to the next scheduled time. Official guidance advises against doubling the amount to compensate for a missed dose.

Q: Are there any common over-the-counter supplements that should be avoided while using Open?

A: While the focus is usually on prescription drug interactions, some health authorities advise considering the use of herbal remedies and nutritional supplements when using Open. To minimize potential effects on absorption, regulatory-associated health information advises separating the administration of Open from these products by at least two hours.

Q: How long does Open stay in the body after the last use?

A: Phenoxymethylpenicillin has a short elimination half-life, meaning it is quickly cleared from the bloodstream. Regulatory pharmacokinetic data indicates its half-life is typically around 30 to 60 minutes, with the medicine primarily being excreted by the kidneys.

Q: What are the official guidelines for stopping the use of Open?

A: The importance of completing the entire course is stated in regulatory documents, even if a patient experiences early symptom improvement. Regulatory warnings indicate that premature cessation is associated with risks such as relapse or the development of non-susceptible organisms.

Q: Is Open safe to use for an extended period?

A: For treating an acute infection, Open is prescribed for a relatively short duration, often 5 to 10 days. However, it is also used for long-term prophylaxis (prevention) of certain conditions, and when prescribed for prolonged periods for preventative uses, official guidelines require medical monitoring.

Q: Can Open interact with birth control pills?

A: Yes, official product information for Open indicates that it may potentially reduce the effectiveness of hormonal contraceptives, such as the combined oral contraceptive pill. Official regulatory guidance advises that non-hormonal barrier methods of contraception may be necessary while using this medication.

Q: Is Open a controlled substance?

A: No, Phenoxymethylpenicillin is not classified as a controlled substance. It is designated as a prescription-only medicine (Rx-only).

Q: Can Open cause changes in sleep patterns?

A: Changes in sleep patterns are not listed among the common side effects of Open. However, rare instances of neurotoxicity have been reported with high doses, which could manifest as drowsiness or other central nervous system effects.

Q: What does the term 'contraindication' mean in relation to Open?

A: A contraindication is a regulatory term for a specific condition or situation where the medicine should absolutely not be used because it could be harmful. For Open, the absolute contraindication is a known history of an allergic reaction or hypersensitivity to penicillin or any of its ingredients.

Q: What is the legal classification of Open?

A: Open, or Phenoxymethylpenicillin, is classified as a prescription-only medicine (POM) across regulatory jurisdictions, meaning it must be dispensed by a pharmacist with a valid prescription.

Q: Is it normal to feel tired when first starting Open?

A: Tiredness or fatigue is not typically listed among the common side effects of Open. While rare serious side effects, such as hemolytic anemia, may cause lack of energy, tiredness alone is not a frequently reported adverse reaction.

Q: Does Open affect blood pressure or heart rate?

A: Official labeling lists a decrease in blood pressure as a rare side effect. More critically, a severe allergic reaction (anaphylaxis), which is a rare but serious adverse event, can cause rapid changes in heart rate and a severe drop in blood pressure.

Q: How does Open interact with alcohol?

A: Regulatory health authorities state that there is generally no known adverse interaction between Open and alcohol. There is no official regulatory statement on whether alcohol consumption interferes with recovery from the underlying infection.

Q: What kind of specialist typically prescribes Open?

A: Open is widely used for common bacterial infections and is frequently prescribed by general practitioners (GPs) and primary care doctors. It may also be supplied by trained pharmacists under specific protocols for certain mild infections.

Q: Is there a maximum time Open can be used according to regulatory sources?

A: For treatment, the course is usually short (5 to 10 days). However, regulatory information confirms that for specific preventative uses, Open may be prescribed on a continuous, long-term basis, potentially for years, as directed by a healthcare provider.

Q: What is the risk of overdose with Open?

A: Official information indicates that taking one dose more than the prescribed amount is generally not associated with severe adverse events, but high doses are associated with a risk of neurotoxicity and gastrointestinal symptoms like feeling sick and diarrhea.

How should Open be stored and disposed of?

The storage and handling requirements for Phenoxymethylpenicillin (Open) are defined by the specific formulation. Tablets must be stored at controlled room temperature (20 C to 25 C) and protected from moisture by keeping the container tightly closed. The oral suspension must be refrigerated (2 C to 8 C) after mixing and must not be frozen. Any unused reconstituted suspension must be discarded within 14 days.

All forms must be kept out of the sight and reach of children. Unused or expired medication should be disposed of through established drug take-back programs or local collection points. Regulatory instructions advise against disposal via household wastewater.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Open found in:

A-Z Index: